Inhibitor antibodies against tissue factor pathway

monoclonal antibody capable of specifically binding the domain of K2 pathway inhibitor of tissue factor (TFPI), wherein said antibody is capable of specifically binding to an epitope comprising residue R17 SEQ ID NO: 2 and KD of said antibody is less than 0.8 nM, as determined using surface plasmon resonance.